Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
29 participants
OBSERVATIONAL
2023-04-03
2025-12-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults
NCT06816459
Nicotine Vapor Specific Sensory Measurement
NCT04533542
Impact of Flavors on Nicotine Perception and Self-Administration Via E-cigarettes
NCT04038515
Experimental Tobacco Marketplace in Regulating Flavored Tobacco Products in Menthol Cigarette Smokers
NCT03897530
Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers
NCT00711100
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. Develop consumer (untrained) sensory panels to identify and assess characterizing flavors in electronic (e)-liquids.
OUTLINE:
Non-user panelists smell and user panelists puff flavored e-liquids and answer questions about the products.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational (smell or puff e-liquids)
All panel participants smell and user panelists puff flavored e-liquids and answer questions about the products.
Behavioral Intervention
Smell or puff e-liquids
Questionnaire Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavioral Intervention
Smell or puff e-liquids
Questionnaire Administration
Ancillary studies
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* CONSUMER USER: No concurrent use of other tobacco products
* CONSUMER USER: General good health
* CONSUMER USER: No allergies
* CONSUMER USER: No self-reported taste or smell deficits
* CONSUMER USER: Not pregnant or lactating
* CONSUMER USER: No medications known to interfere with taste/smell
* CONSUMER USER: Passing scores on the Brief Smell Identification Test (B-SIT), phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell and taste tests
* CONSUMER USER: No positive diagnosis of COVID-19 within 30 days
* CONSUMER NONUSER: No use of tobacco or nicotine products in the last year
* CONSUMER NONUSER: General good health
* CONSUMER NONUSER: No allergies
* CONSUMER NONUSER: No self-reported taste or smell deficits
* CONSUMER NONUSER: Not pregnant or lactating
* CONSUMER NONUSER: No medications known to interfere with taste/smell
* CONSUMER NONUSER: Passing scores on the Brief Smell Identification Test (B-SIT), phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell and taste tests
* CONSUMER NONUSER: No positive diagnosis of COVID-19 within 30 days
Exclusion Criteria
* CONSUMER USER: Not current daily vapers
* CONSUMER USER: Concurrent use of other tobacco products
* CONSUMER USER: Fair or poor general health
* CONSUMER USER: Allergies
* CONSUMER USER: Self-reported taste or smell deficits
* CONSUMER USER: Pregnant or lactating
* CONSUMER USER: Medications known to interfere with taste/smell
* CONSUMER USER: Failing scores on the Brief Smell Identification Test (B-SIT), phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell and taste tests
* CONSUMER USER: Positive diagnosis of COVID-19 within 30 days
* CONSUMER NONUSER: Outside age range
* CONSUMER NONUSER: Use of tobacco or nicotine products in the last year
* CONSUMER NONUSER: Fair or poor general health
* CONSUMER NONUSER: Allergies
* CONSUMER NONUSER: Self-reported taste or smell deficits
* CONSUMER NONUSER: Pregnant or lactating
* CONSUMER NONUSER: Medications known to interfere with taste/smell
* CONSUMER NONUSER: Failing scores on the Brief Smell Identification Test (B-SIT), phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell and taste tests
* CONSUMER NONUSER: Positive diagnosis of COVID-19 within 30 days
21 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
University of Rochester
OTHER
Roswell Park Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard J O'Connor
Role: PRINCIPAL_INVESTIGATOR
Roswell Park Cancer Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Roswell Park Cancer Institute
Buffalo, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2019-06320
Identifier Type: REGISTRY
Identifier Source: secondary_id
I 80518
Identifier Type: OTHER
Identifier Source: secondary_id
I 80518
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.